NHS Now Offers New Non-HRT Drug for Menopause Hot Flushes & Night Sweats

NHS Now Offers New Non-HRT Drug for Menopause Hot Flushes & Night Sweats

For women experiencing debilitating hot flushes and night sweats during menopause, a new non-hormonal treatment option is now available on the National Health Service (NHS) in England. The medication, known as Veoza (fezolinetant), offers a potential alternative for those unable to utilize hormone replacement therapy (HRT) or who prefer a different approach to managing their … Read more

Sleep Apnea Often Goes Undiagnosed Due to Vague Symptoms | rodi.nl

Many people suffer from sleep disorders, but often the underlying cause remains undiagnosed. A common, yet frequently overlooked condition is sleep apnea, a potentially serious disorder where breathing repeatedly stops and starts during sleep. Longarts Erik Kapteijns of the Heemskerk Sleep Center, affiliated with the Red Cross Hospital, emphasizes the importance of recognizing the often … Read more

Contraception Coverage: Private Insurance & Medicaid Requirements (2025)

Contraception Coverage: Private Insurance & Medicaid Requirements (2025)

The increasing availability of over-the-counter (OTC) oral contraceptives represents a significant step toward expanding access to reproductive healthcare, but navigating insurance coverage remains complex. While the Food and Drug Administration (FDA) has approved several oral contraceptives for sale without a prescription, ensuring these medications are affordable—and covered by insurance—is proving to be a challenge. The … Read more

BioNTech Founders Step Down to Focus on AI-Powered mRNA Therapies

BioNTech Founders Step Down to Focus on AI-Powered mRNA Therapies

Mainz, Germany – In a significant shift for the biotechnology landscape, the co-founders of BioNTech, Professors Ugur Sahin and Özlem Türeci, are stepping down from their leadership roles to dedicate themselves to a fresh venture focused on next-generation mRNA innovations. This move, announced on March 10, 2026, signals a strategic realignment for both BioNTech and … Read more